<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(8)</volume><submitter>Nocturne G</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To investigate DKK-1 and SOST serum levels among patients with recent inflammatory back pain (IBP) fulfilling ASAS criteria for SpA and associated factors.&lt;h4>Methods&lt;/h4>The DESIR cohort is a prospective, multicenter French cohort of 708 patients with early IBP (duration >3 months and &lt;3 years) suggestive of AxSpA. DKK-1 and SOST serum levels were assessed at baseline and were compared between the subgroup of patients fulfilling ASAS criteria for SpA (n = 486; 68.6%) and 80 healthy controls.&lt;h4>Results&lt;/h4>Mean SOST serum levels were lower in ASAS+ patients than healthy controls (49.21 ± 25.9 vs. 87.8 ± 26 pmol/L; p&lt;0.0001). In multivariate analysis, age (p = 5.4 10-9), CRP level (p&lt;0.0001) and serum DKK-1 level (p = 0.001) were associated with SOST level. Mean DKK-1 se</pubmed_abstract><journal>PloS one</journal><pagination>e0134974</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4552086</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort.</pubmed_title><pmcid>PMC4552086</pmcid><pubmed_authors>Boudaoud S</pubmed_authors><pubmed_authors>Berenbaum F</pubmed_authors><pubmed_authors>Taylor KE</pubmed_authors><pubmed_authors>Roux C</pubmed_authors><pubmed_authors>Criswell LA</pubmed_authors><pubmed_authors>Dougados M</pubmed_authors><pubmed_authors>van der Heijde D</pubmed_authors><pubmed_authors>Mariette X</pubmed_authors><pubmed_authors>Seror R</pubmed_authors><pubmed_authors>van Gaalen F</pubmed_authors><pubmed_authors>Chanson P</pubmed_authors><pubmed_authors>Goupille P</pubmed_authors><pubmed_authors>Dieude P</pubmed_authors><pubmed_authors>Pavy S</pubmed_authors><pubmed_authors>Briot K</pubmed_authors><pubmed_authors>Feydy A</pubmed_authors><pubmed_authors>Nithitham J</pubmed_authors><pubmed_authors>Claudepierre P</pubmed_authors><pubmed_authors>Miceli-Richard C</pubmed_authors><pubmed_authors>Nocturne G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort.</name><description>&lt;h4>Objectives&lt;/h4>To investigate DKK-1 and SOST serum levels among patients with recent inflammatory back pain (IBP) fulfilling ASAS criteria for SpA and associated factors.&lt;h4>Methods&lt;/h4>The DESIR cohort is a prospective, multicenter French cohort of 708 patients with early IBP (duration >3 months and &lt;3 years) suggestive of AxSpA. DKK-1 and SOST serum levels were assessed at baseline and were compared between the subgroup of patients fulfilling ASAS criteria for SpA (n = 486; 68.6%) and 80 healthy controls.&lt;h4>Results&lt;/h4>Mean SOST serum levels were lower in ASAS+ patients than healthy controls (49.21 ± 25.9 vs. 87.8 ± 26 pmol/L; p&lt;0.0001). In multivariate analysis, age (p = 5.4 10-9), CRP level (p&lt;0.0001) and serum DKK-1 level (p = 0.001) were associated with SOST level. Mean DKK-1 se</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2026-04-08T16:27:44.424Z</modification><creation>2019-03-26T23:35:31Z</creation></dates><accession>S-EPMC4552086</accession><cross_references><pubmed>26313358</pubmed><doi>10.1371/journal.pone.0134974</doi></cross_references></HashMap>